In a report released yesterday, Steven Valiquette from Barclays maintained a Hold rating on Welltower (WELL), with a price target of $46.00. The company’s shares closed last Wednesday at $44.29.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 2.6% and a 52.2% success rate. Valiquette covers the Healthcare sector, focusing on stocks such as Capital Senior Living, Molina Healthcare, and Community Health.
Currently, the analyst consensus on Welltower is a Hold with an average price target of $59.91, implying a 32.3% upside from current levels. In a report issued on April 7, Citigroup also maintained a Hold rating on the stock with a $42.00 price target.
See today’s analyst top recommended stocks >>
Welltower’s market cap is currently $18.18B and has a P/E ratio of 14.40. The company has a Price to Book ratio of 1.16.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Welltower, Inc. engages in the provision of health care infrastructure and investment of seniors housing operators, post-acute providers, and health systems. It operates through the following segments: Seniors Housing Operating, Triple-net, and Outpatient Medical. The Seniors Housing Operating segment includes the seniors housing communities. The Triple-net segment offers long-term/post-acute care facilities, assisted living facilities, independent living/continuing care retirement communities, care homes (United Kingdom), independent support living facilities (Canada), care homes with nursing (United Kingdom), and combinations thereof. The Outpatient Medical segment provides outpatient medical buildings. The company was founded by Bruce G. Thompson and Fritz Wolfe in 1970 and is headquartered in Toledo, OH.
